Press Releases
Aug 8, 2022

- Winner developed app to empower cancer patients after experience as a cancer caregiver - NORTHBROOK, Ill., Aug. 8, 2022 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") today announced the...

Aug 1, 2022

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the following changes to its management structure effective October 1, 2022. 1. Top...

Jul 26, 2022

– Companies plan to discuss results with regulatory authorities – TOKYO and BOTHELL, Wash., July 26, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa,...

EXPLORE ALL US PRESS RELEASES

Articles
Jul 20, 2022

Our consistent score of 100 recognizes our continuing effort to create an inclusive culture for people with disabilities. For the third year in a row, Astellas has been included in the Disability...

Jul 14, 2022

Astellas Pharma US President Mark Reisenauer recently joined PhRMA Senior Vice President of State Advocacy Scott LaGanga for a conversation about a range of topics that are important to patients...

Jun 14, 2022

Great Place to Work and Fortune magazine have honored Astellas as one of this year’s Best Workplaces in Chicago. Astellas, ranked #X, is among the best companies to work for headquartered in...

EXPLORE ALL ARTICLES

Stay Connected

Get only the email alerts you want.

Subscribe

Media Contacts

 

For media inquiries and reporter requests, please click here to fill out a request form.

Our communications team will respond to verified media requests within 24-48 hours as appropriate.

If you are not a reporter and need assistance, please visit our contact us page that includes information for patients, healthcare providers and researchers.

 

Astellas on Twitter
Download Fact Sheet
Sustainability
Investors
Explore U.S. Products